11 – 20 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
Borg, David LU ; Sundberg, Jan ; Brun, Eva LU ; Kjellén, Elisabeth LU ; Petersson, Kristoffer LU ; Hermansson, Michael LU ; Johansson, Jan LU
; Eberhard, Jakob
LU
and Johnsson, Anders
LU
(2020)
In Acta Oncologica
59(2).
p.212-218
- Contribution to journal › Article
- 2019
-
Mark
Towards improved oncological treatment of esophageal and gastric cancer. Clinical and translational studies.
- Thesis › Doctoral thesis (compilation)
-
Mark
Expression of PD-L1 and PD-1 in chemoradiotherapy-Naïve esophageal and gastric adenocarcinoma : Relationship with mismatch repair status and survival
Svensson, Maria C. LU ; Borg, David LU ; Zhang, Cheng ; Hedner, Charlotta LU ; Nodin, Björn LU ; Uhlén, Mathias ; Mardinoglu, Adil ; Leandersson, Karin LU
and Jirström, Karin
LU
(2019)
In Frontiers in Oncology
9(MAR).
- Contribution to journal › Article
- 2018
-
Mark
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment
Hedner, Charlotta LU ; Borg, David LU ; Nodin, Björn LU ; Karnevi, Emelie LU ; Jirström, Karin LU
and Eberhard, Jakob
LU
(2018)
In Journal of Clinical Pathology
71(5).
p.451-462
- Contribution to journal › Article
-
Mark
Prognostic significance of lymphocyte-activation gene-3 expression in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma
Siesing, C. LU ; Svensson, M. C. LU ; Hedner, C. LU ; Nodin, B. LU ; Borg, D. LU and Jirstrom, K. LU
(2018)
In Annals of oncology : official journal of the European Society for Medical Oncology
29(Suppl. 8).
p.220-220
- Contribution to journal › Published meeting abstract
-
Mark
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
Borg, David LU ; Larsson, Anna H. LU ; Hedner, Charlotta LU ; Nodin, Björn LU ; Johnsson, Anders LU and Jirström, Karin LU
(2018)
In Journal of Translational Medicine
16(1).
- Contribution to journal › Article
- 2017
-
Mark
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4) : A multicentre, open-label, randomised, phase 3 trial
- Contribution to journal › Article
-
Mark
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
Svensson, Maria C LU ; Warfvinge, Carl Fredrik LU ; Fristedt, Richard LU ; Hedner, Charlotta LU ; Borg, David LU ; Eberhard, Jakob LU ; Micke, Patrick ; Nodin, Björn LU ; Leandersson, Karin LU
and Jirström, Karin
LU
(2017)
In Oncotarget
8(42).
p.72108-72126
- Contribution to journal › Article
-
Mark
Does Early Palliative Care Improve Quality of Life for Patients with Incurable Gastro-intestinal Cancers? A Randomized Study
- Contribution to conference › Poster
- 2016
-
Mark
Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
Hedner, Charlotta LU ; Borg, David LU ; Nodin, Björn LU ; Karnevi, Emelie LU ; Jirström, Karin LU
and Eberhard, Jakob
LU
(2016)
In PLoS ONE
11(2).
- Contribution to journal › Article